| CAS号 | 名称 | 物化性质 | 分子式 | 分子量 |
| 12619-70-4 | 环糊精
Cyclodextrin | |
| |
| 12619-68-0 | cobalt boride, mixture of 2:1 and 3:1 | |
| |
| 12619-61-3 | aurantin | |
| |
| 126172-94-9 | 2,6-bis(4-aminophenyl)-4-(4-(dimethylamino)phenyl)thiopyrylium | |
| |
| 319-24-4 | 2-氨基-5-氟苯甲酸甲酯
2-Amino-5-fluorobenzoic acid methyl ester | 密度：1.260
熔点：34-37°C
沸点：265.3°C
|
C8H8FNO2 | 169.16 |
| 126168-33-0 | 2,9-dimethyl-1-heptyl-3-methoxy-9h-carbazol | |
| |
| 126168-32-9 | 1-heptyl-2-methyl-9h-carbazol-3-o | |
| |
| 126167-89-3 | javanicin d | |
| |
| 126167-88-2 | javanicin a | |
| |
| 126164-79-2 | (z)-((2-amino-5-nitrophenyl)phenylmethylene)phenylthiourea | |
| |
| 126164-78-1 | (z)-((2-amino-5-bromophenyl)phenylmethylene)phenylthiourea | |
| |
| 126164-76-9 | alpha-d-glucopyranosiduronamide, (3-beta,20-beta)-11,29-dioxo-29-(phenylamino)o | |
| |
| 126164-75-8 | alpha-d-glucopyranosiduronamide, (3-beta,20-beta)-29-(nonylamino)-11,29-dioxool | |
| |
| 126164-69-0 | 7))decane-1-carboxylic acid, 3-(4-(acetyloxy)phenyl)-tricyclo(3.3.1.1(sup | |
| |
| 126164-68-9 | tricyclo(3.3.1.1(sup 3,7))decane-1-carboxamide, n-(2,6-dichlorophenyl)-3-(4-hyd | |
| |
| 126164-66-7 | 7))decane-1-carboxylic acid, 3-(4-hydroxyphenyl)-tricyclo(3.3.1.1(sup methy | |
| |
| 126164-65-6 | benzamide, n-(2,6-dichlorophenyl)-2-hydroxy-5-tricyclo(3.3.1.1(sup 3,7))dec-1-y | |
| |
| 126164-64-5 | n-hydroxy-2-oxo-4-phenyl-1-pyrrolidineethanimidamid | |
| |
| 126164-63-4 | n-(acetyloxy)-2-oxo-1-pyrrolidineethanimidamid | |
| |
| 126161-67-9 | hibtiter | |
| |
| 126161-14-6 | betvi protein | |
| |
| 12616-52-3 | staphylococcal alpha-toxin | |
| |
| 12616-36-3 | halowax 1014 | |
| |
| 12616-35-2 | halowax 1013 | |
| |
| 126150-97-8 | bapta-am | 熔点：86-90 °C
|
C34H40N2O18 | 764.69 |
| 126150-87-6 | n-(2-hydroxy-2-(4-(2-phenylethyl)phenyl)ethyl)-formamid | |
| |
| 126150-86-5 | n-(2-oxo-2-(4-(2-phenylethyl)phenyl)ethyl)-formamid | |
| |
| 126149-71-1 | javanicin c | |
| |
| 126147-86-2 | 2,1,3-benzoxadiazole-5-carbonyl chloride | |
C7H3ClN2O2 | |
| 126145-81-1 | (z)-((2-amino-5-chlorophenyl)phenylmethylene)phenylthiourea | |
| |
| 126145-80-0 | (z)-thioure | |
| |
| 126145-79-7 | alpha-d-glucopyranosiduronamide, (3-beta,20-beta)-29-((2-hydroxyethyl)amino)-11 | |
| |
| 126145-78-6 | morpholine, 4-((3-beta,20-beta)-3-((3,4-di-o-acetyl-6-deoxy-6-(4-morpholinyl)-6 | |
| |
| 126145-77-5 | piperidine, 1-((3-beta,20-beta)-3-((3,4-di-o-acetyl-6-deoxy-6-oxo-6-(1-piperidi | |
| |
| 126145-76-4 | alpha-d-glucopyranosiduronamide, (3-beta,20-beta)-29-(cyclohexylamino)-11,29-di | |
| |
| 126145-75-3 | alpha-d-glucopyranosiduronamide, (3-beta,20-beta)-29-(heptadecylamino)-11,29-di | |
| |
| 126145-74-2 | alpha-d-glucopyranosiduronamide, (3-beta,20-beta)-29-(hexylamino)-11,29-dioxool | |
| |
| 126145-52-6 | 2-hydroxy-5-tricyclo(3.3.1.1(sup 3,7))dec-1-yl-benzoic aci methyl ester | |
C18H22O3 | 286.37 |
| 126145-51-5 | 2-hydroxy-5-tricyclo(3.3.1.1(sup 3,7))dec-1-yl-benzoic aci | |
| |
| 126145-47-9 | 1-((5-methyl-1,2,4-oxadiazol-3-yl)methyl)-2-pyrrolidinon | |
| |
| 126145-46-8 | n-hydroxy-alpha-methyl-2-oxo-4-phenyl-1-pyrrolidineethanimidamid | |
| |
| 126145-23-1 | (R)-e | |
| |
| 126144-46-5 | cd4 (81-92 | |
| |
| 126141-95-5 | oncogene protein vav | |
| |
| 12614-71-0 | antibiotic nrc 101 | |
| |
| 126136-49-0 | -terminated, reaction products with isobutylene-isoprene polymer | |
| |
| 126132-83-0 | imciromab | |
| |
| 126128-51-6 | 2-bromo-5-cystein-s-ylhydroquinone | |
| |
| 126128-35-6 | 6h,8h-3,4-dihydropyrimido(4,5-c)(1,2)oxazin-7-one | |
| |
| 126127-93-3 | 3-(1,3-dioxobutyl)-2-((2-methoxyphenoxy)methyl)-thiazolidin | |
| |
